Switzerland · Biotechnology startup

MindMaze

MindMaze is a digital neurotherapeutic platform that provides digital assessments and therapeutics to treat and rehab patients.

Funding reportedLast round: Undisclosed round

BiotechnologyLausanne, Switzerland

What company datasets say MindMaze raised

Funding, as reported

Reported in all340.7Min the source's currency
Rounds10
Last roundUndisclosed round
Last round dateFeb 2022
Investors listed7
Valuation$1.0B, Mar 2026

On 3 portfolio pages

Investors who name them

Each firm lists MindMaze on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.

Biotechnology in Switzerland

Startups like it

Is this your company?

Add your raise, your deck and your story, and put MindMaze in front of investors. Or tell us what we have wrong.